Yili Zhou

508 citations
16 papers · 362 indexed · h-index 10
Topics
Thyroid Cancer Diagnosis and Treatment (10 papers)Cancer-related Molecular Pathways (3 papers)Head and Neck Anomalies (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Yili Zhou

15 papers receiving 359 citations

Peers

Yili Zhou
Comparison fields: 5 of 53
  • Endocrinology, Diabetes and Metabolism 233
  • Molecular Biology 119
  • Surgery 95
  • Oncology 71
  • Cancer Research 65
Replace Laís Moraes with:
Laís Moraes Brazil
Mats Grände Sweden
Christina Stache Germany
Kirsten A. Ward‐Hartstonge New Zealand
Mirela Diana Ilie France
Araceli García‐Martínez Spain
Cláudia Miranda Italy
Qungen Xiao China
Yourha Kim South Korea
Andréa Alex Schiavo Belgium
Yili Zhou relative to Laís Moraes Brazil Laís Moraes's profile →
Citations per field
00.5×2.8×
Laís Moraes · 1×
Citations per year

Countries citing papers authored by Yili Zhou

Since Specialization
Citations

This map shows the geographic impact of Yili Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yili Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yili Zhou more than expected).

Fields of papers citing papers by Yili Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yili Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yili Zhou. The network helps show where Yili Zhou may publish in the future.

Co-authorship network of co-authors of Yili Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yili Zhou. A scholar is included among the top collaborators of Yili Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yili Zhou. Yili Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 4
3 1
4
Downregulated CDH3 decreases proliferation, migration, and invasion in thyroid cancer.
16
5 4
6 21
7 10
8 98
9 4
10 39
11 14
12 33
13 22
14 66
15 24
16 6

About Yili Zhou

Yili Zhou is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Pathology and Forensic Medicine, having authored 16 papers that have together received 362 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), Cancer-related Molecular Pathways (3 papers) and Head and Neck Anomalies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (233 citations), Cancer Research (65 citations) and Anatomy (5 citations). Yili Zhou has collaborated with scholars based in China and United States. Frequent co-authors include Xiaohua Zhang, Ouchen Wang, Gui-Long Guo, Xuanxuan Dai, Han Yang, Wei Zhang, Yefeng Cai, Yehuan Liu, Langping Jin and Endong Chen. Their work appears in journals such as Oncotarget, Journal of Nanoparticle Research and Molecular Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026